QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in 6.3

Sort by
1 items

  • Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug

    Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
    CNBC - 10h
  • 1
  Follow topic
© 2025 QuikReader - About - Terms - Privacy